Business Context and Reporting Period
Company: Creative Medical Technology Holdings, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: April 26, 2018 (Earliest event reported)
Reporting Period: Events occurred between April 20, 2018, and April 27, 2018.
Key Financial Metrics
This filing does not provide data on revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on equity transactions.
Material Changes
The company reported significant unregistered sales of equity securities under Item 3.02:
- Note Conversions: Issued 13,566,753 shares upon conversion of outstanding notes.
- Warrant Exercises: Issued 28,548,513 shares upon cashless exercise of outstanding warrants.
- Total Issuance: 42,115,266 shares issued during the period.
- Exemption: Transactions conducted pursuant to Section 3(a)(9) of the Securities Act of 1933.
- Post-Transaction Share Count: 641,502,996 shares of common stock outstanding as of April 27, 2018.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, risk factors, or discussion of contingencies. The document is a procedural disclosure of the equity issuances described above.
Investor Verification Checklist
- Verify the total number of outstanding shares (641,502,996) against subsequent filings to confirm no further dilution.
- Review the terms of the converted notes and exercised warrants to understand the valuation assumptions used for the cashless exercise.
- Confirm the company's compliance with Section 3(a)(9) exemptions for these specific transactions.
- Check for any related press releases or 10-Q/10-K filings that may provide context on the debt levels prior to conversion.